OMOROGIUWA ADENEYE: Open Payments
NPI 1770271280 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $62 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Lundbeck LLC | 2 | $42 |
| ABBVIE INC. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, VRAYLAR, TRINTELLIX, REXULTI.
Industry payments across CA — which companies pay providers there.
